tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

CapsoVision Raises $600,000 Through IPO Overallotment

Story Highlights
CapsoVision Raises $600,000 Through IPO Overallotment

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

The latest update is out from CapsoVision, Inc. ( (CV) ).

On July 15, 2025, CapsoVision, Inc. entered into a development agreement with Canon Inc. to create CMOS image sensor samples for future versions of its capsule endoscopies, with a development fee of approximately $4.1 million. Additionally, on July 16, 2025, the company raised approximately $600,000 through an overallotment exercise of its initial public offering, issuing additional shares and warrants, which are subject to a 180-day restriction period.

More about CapsoVision, Inc.

CapsoVision, Inc. operates in the medical technology industry, specializing in capsule endoscopy solutions. The company offers products like CapsoCam Plus for small bowel examinations and is advancing its CapsoCam Colon for large bowel diagnostics, with a focus on obtaining FDA clearances for its innovations.

Average Trading Volume: 1,104,172

Find detailed analytics on CV stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1